Donate
Email Password
Not a member? Sign Up   Forgot password?
Business and Economics Education Environment Health Care California
Home
About PRI
My PRI
Contact
Search
Policy Research Areas
Events
Publications
Press Room
PRI Blog
Jobs Internships
Scholars
Staff
Book Store
Policy Cast
Upcoming Events
WSJ's Stephen Moore Book Signing Luncheon-Rescheduled for December 17
12.17.2012 12:00:00 PM
Who's the Fairest of Them All?: The Truth About Opportunity, ... 
More

Recent Events
Victor Davis Hanson Orange County Luncheon December 5, 2012
12.5.2012 12:00:00 PM

Post Election: A Roadmap for America's Future

 More

Post Election Analysis with George F. Will & Special Award Presentation to Sal Khan of the Khan Academy
11.9.2012 6:00:00 PM

Pacific Research Institute Annual Gala Dinner

 More

Reading Law: The Interpretation of Legal Texts
10.19.2012 5:00:00 PM
Author Book Signing and Reception with U.S. Supreme Court Justice ... More

Opinion Journal Federation
Town Hall silver partner
Lawsuit abuse victims project
Press Archive
E-mail Print Jaundiced View Excludes Idea of Charitable Acts
Health Care Op-Ed
By: Sally C. Pipes
7.23.2004

Financial Times, July 23, 2004

LETTERS TO THE EDITOR:

Sir, In her seething column "Big pharma is a two-faced friend" (July 19), Marcia Angell is furious at Pfizer for giving discount drugs to uninsured Americans. Apparently, offering cheaper drugs to low-income people is nothing but a cynical public relations ploy by the pharmaceutical industry.

In her jaundiced world view, Dr Angell cannot seem to accept that a big company could ever engage in an act of charity. To her, it is all a big corporate conspiracy. She even suggests that Pfizer is discounting drugs as part of some twisted tax-evasion scheme, noting that Pfizer "could come out ahead if it gets a large enough tax deduction". No good deed goes unpunished, and Dr Angell seems determined to break Pfizer on the wheel. She rages on that the pharmaceutical industry "needs to curb its greed". Bold language for someone who lectures in the rarefied halls of Harvard Medical School, which charges an annual tuition fee of about $28,000.

After excoriating Pfizer, Dr Angell declares that Americans are angry because it is illegal to reimport drugs from Canada. She complains that "Canadians can get exactly the same drugs for half to two-thirds the price". That is simply not true. My uncle died five years ago from non-Hodgkin's lymphoma. The American drug Rituxan that might have helped him was not available in Canada.

Before Dr Angell decides to write another anti-pharmaceutical screed, she ought to at least get her facts straight.


Sally C. Pipes is president and CEO of the San Francisco-based Pacific Research Institute. She can be reached at spipes@pacificresearch.org.
Submit to: 
Submit to: Digg Submit to: Del.icio.us Submit to: Facebook Submit to: StumbleUpon Submit to: Newsvine Submit to: Reddit
Within Press
Browse by
Recent Publications
Press Archive
Powered by eResources